Retrospective review of a series of patients with cutaneous sarcoidosis. To characterize the phenotype of patients with isolated cutaneous sarcoidosis and to assess the temporal relationship between cutaneous and systemic disease. To review clinical and histological features of patients with cutaneous sarcoidosis and the risk of progression to systemic disease. Larger and more extensive investigations are required to further assess the adverse effect profile and optimal dosing for managing cutaneous sarcoidosis.Ĭutaneous lesions of sarcoidosis can allow physicians to establish the diagnosis of a systemic disease, but the need of monitoring patients presenting skin limited sarcoidosis in order to detect further extracutaneous involvement has rarely been evaluated. There were also scattered reports of etanercept, rituximab, golimumab, and ustekinumab being utilized as third-line agents with varying degrees of success. Although somewhat limited, the data in published studies support the use of both infliximab and adalimumab as third-line treatments for chronic or resistant cutaneous sarcoidosis. In this article, we reviewed the currently available English-language publications on the use of biologics in managing cutaneous sarcoidosis. Biologics are an emerging treatment option for the management of cutaneous sarcoidosis, but their role in management is not well-defined. Second-line agents include tetracyclines, hydroxychloroquine, and methotrexate. The accepted first-line therapy for cutaneous sarcoidosis consists of intralesional and oral corticosteroids, but these can fail in the face of resistant disease and corticosteroid-induced adverse effects. Cutaneous manifestations of sarcoidosis can impose a significant detriment to patients’ quality of life. It can affect a number of organ systems, most commonly the lungs, lymph nodes, and skin. Recommended: Add cable to secure your tablet ($34.Sarcoidosis is an inflammatory disease defined by the presence of non-caseating granulomas. Universal (Compatible with standard T-Bar™ design lock slots) Recommended: Add cable to secure your tablet ($34.95) Galaxy Tab S2 8" silicon edge case - Black IPad Mini 8.3" (6th Gen.) Silicon Edge Case IPad 10.2" / iPad Air 10.5" Silicon Edge Case Recommended: Add Edge Case to your tablet This extra mobility of the tablet enhances ADA (Americans with Disabilities Act) compliance, as it enables anyone to lift the tablet and hold it by hand or change its viewing angle.Īmazon Fire 8 and Amazon Fire 10 (HD) tablets and other Amazon Fire models This offers an easy way to lift the tablet and dock it back to place on the magnetic mount. The kit also includes the Adhesive Plate with Lock Slot that is fixed on any tablet or iPad and docks to the Magnets. The included Cable Lock provides the necessary security when connected to the tablet, and the Wall Mount acts as an elegant and efficient way to display the tablet. The Magnetix Wall Mount kit consists of a 100mm VESA compatible mounting bracket with Lock Slot that can be fixed to any flat surface and a corresponding 100mm VESA Magnetix Mount. This provides a comfortable and elegant way to easily interact with customers and perform tasks including reading and signing papers, registration, and many other self-service actions without the concern of theft. Thanks to a unique customer-oriented design, the Magnetix allows you to lift and hold the tablet, while it is secured to its base with a cable lock. Magnetix is an all-in-one universal solution that works with all iPads and Tablet brands and sizes, and enables you to display, secure, and hold the tablet by hand. Bring flexibility to your business and procedures with this unique Tablet and iPad display and security solution.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |